/newsroom/ en /newsroom/news/list/2022/06/17/south-australian-omicron-covid-19-booster-vaccine-starting-human-trials A cutting-edge DNA vaccine designed by ×îÐÂÌÇÐÄVlog of Adelaide researchers and manufactured in South ×îÐÂÌÇÐÄVlog targeting the highly-transmissible Omicron COVID-19 variant – and can be easily adapted to future variants – is starting human trials this week. June 19 2022 Lee Gaskin /newsroom/news/list/2022/06/17/south-australian-omicron-covid-19-booster-vaccine-starting-human-trials /newsroom/news/list/2021/12/16/parents-more-likely-to-refuse-covid-jab-for-children-than-adults In a study of South ×îÐÂÌÇÐÄVlogn households, researchers at the ×îÐÂÌÇÐÄVlog of Adelaide have found parents are more likely to refuse COVID-19 vaccination for their child than the proportion of adults refusing vaccination for themselves. December 16 2021 Kelly Brown /newsroom/news/list/2021/12/16/parents-more-likely-to-refuse-covid-jab-for-children-than-adults /newsroom/news/list/2021/05/11/sa-ready-to-lead-covid-19-vaccine-production South ×îÐÂÌÇÐÄVlog is uniquely placed to play a vital role in expediting the nation’s COVID-19 vaccine rollout. May 12 2021 David Ellis /newsroom/news/list/2021/05/11/sa-ready-to-lead-covid-19-vaccine-production /newsroom/news/list/2020/09/21/adelaide-has-key-role-in-covid-19-vaccine-human-trials ×îÐÂÌÇÐÄVlog of Adelaide researchers are playing a leading role in the human trials of ×îÐÂÌÇÐÄVlog’s first needle-free, gene-based COVID-19 vaccine. September 21 2020 David Ellis /newsroom/news/list/2020/09/21/adelaide-has-key-role-in-covid-19-vaccine-human-trials